Walleye Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Sell
61,700
-35,300
-36% -$1.92M 0.01% 1294
2026
Q1
$6.09M Sell
97,000
-77,300
-44% -$6.18M 0.03% 682
2025
Q4
$16.6M Buy
174,300
+2,000
+1% +$196K 0.05% 378
2025
Q3
$16.8M Buy
172,300
+62,000
+56% +$6.42M 0.06% 316
2025
Q2
$11.8M Sell
110,300
-59,400
-35% -$6.01M 0.05% 426
2025
Q1
$17.1M Sell
169,700
-171,600
-50% -$17.3M 0.08% 251
2024
Q4
$30.5M Buy
341,300
+17,200
+5% +$1.51M 0.07% 210
2024
Q3
$27.2M Sell
324,100
-69,300
-18% -$5.46M 0.06% 240
2024
Q2
$30.3M Sell
393,400
-89,200
-18% -$6.53M 0.05% 220
2024
Q1
$33.1M Buy
482,600
+103,200
+27% +$6.64M 0.06% 232
2023
Q4
$21.9M Buy
379,400
+83,000
+28% +$4.43M 0.05% 291
2023
Q3
$15.6M Buy
296,400
+166,000
+127% +$8.71M 0.04% 355
2023
Q2
$7.05M Buy
130,400
+129,500
+14,389% +$6.76M 0.03% 558
2023
Q1
$45K Buy
+900
New +$42.4K ﹤0.01% 3233
2019
Q4
Sell
-16,000
Closed -$651K 1813
2019
Q3
$651K Buy
+16,000
New +$678K 0.04% 627
2019
Q2
Sell
-200
Closed -$8K 1744
2019
Q1
$8K Buy
+200
New +$7.64K ﹤0.01% 1416

Other funds holding BSX

Walleye Capital's BSX Position: Q2 2026 in Review

Walleye Capital increased its Boston Scientific (BSX) stake by 89% in Q2 2026, buying an estimated $40.3M and bringing the position to 1,578,172 shares worth $67.4M. The position accounts for 0.24% of the portfolio, ranked #45.

Walleye Capital first reported a position in BSX in Q2 2020 and has held it in 23 quarters since. The position peaked at $195M in Q4 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Walleye Capital held 1,578,172 shares of Boston Scientific worth $67.4M as of Q2 2026.
  • Walleye Capital bought 742,220 Boston Scientific shares in Q2 2026, an estimated $40.3M.
  • Boston Scientific made up 0.24% of Walleye Capital's portfolio in Q2 2026, its #45 holding.
  • Walleye Capital first reported a position in Boston Scientific in Q2 2020 and has held it in 23 quarters since.
  • Walleye Capital's Boston Scientific position peaked at $195M in Q4 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.